User:Bruna Oliveira de Almeida/Sandbox 1
From Proteopedia
(Difference between revisions)
Line 19: | Line 19: | ||
===NiRAN and β-hairpin domain=== | ===NiRAN and β-hairpin domain=== | ||
- | The complete SARS-CoV-2 RdRp protein structure obtained by cryo-EM<ref name="structure1"/><ref name="Wanchao"> PMID: 32358203<ref/>(2,10) allowed to resolve the N-terminal portion of the NiRAN domain as well to identify a N-terminal β-hairpin domain, what was in part unresolved for SARS-CoV RdRp protein <ref name="robert" /> (8). It was found that this β-hairpin is inserted in the groove clamped by the NiRAN domain and the palm subdomain and it forms close contacts that help to stabilize the overall structure<ref name="structure1"/> (2). | + | The complete SARS-CoV-2 RdRp protein structure obtained by cryo-EM<ref name="structure1"/> <ref name="Wanchao"> PMID: 32358203 <ref/>(2,10) allowed to resolve the N-terminal portion of the NiRAN domain as well to identify a N-terminal β-hairpin domain, what was in part unresolved for SARS-CoV RdRp protein <ref name="robert" /> (8). It was found that this β-hairpin is inserted in the groove clamped by the NiRAN domain and the palm subdomain and it forms close contacts that help to stabilize the overall structure<ref name="structure1"/> (2). |
==An attractive drug target== | ==An attractive drug target== | ||
- | As has been shown, SARS-CoV-2 RdRp protein is crucial for viral replication and so, it has been an important drug target in the fight against COVID-19<ref name="structure1"/> (2,11). In fact, growing attention has been given to RdRp as target of a class of antiviral drugs known as nucleotide analogs, including Remdesivir | + | As has been shown, SARS-CoV-2 RdRp protein is crucial for viral replication and so, it has been an important drug target in the fight against COVID-19<ref name="structure1"/> (2,11). In fact, growing attention has been given to RdRp as target of a class of antiviral drugs known as nucleotide analogs, including Remdesivir (10,12). Remdesivir is an adenosine monophosphate analog and it is converted into its active drug form (its triphosphate form) within the cells (13). It is positioned at the center of the catalytic active site and, as for other nucleotide analogs, Remdesivir was shown to inhibits the RdRp activity through non-obligate RNA chain termination, which requires the conversion of its monophosphate form to the triphosphate one (10). In a recent study (10), it was described some differences between the apo and the complex (with Remdesivir and a template RNA) structures, showing some small conformational changes between them. (The three dimensional structure of the nsp12-nsp7-nsp8 complex bounded to the template-primer RNA and triphosphate form of Remdesivir can be seen in https://www.rcsb.org/3d-view/7BV2). |
== References == | == References == |
Revision as of 02:07, 14 June 2020
SARS-CoV-2 RNA-dependent RNA polymerase
|